Literature DB >> 26785731

Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: lesson from insulinoma.

Hridayesh Prakash1, Felix Klug1, Vinod Nadella2, Varadendra Mazumdar2, Hubertus Schmitz-Winnenthal3, Liudmila Umansky1.   

Abstract

Tumor infiltrating iNOS+ macrophages under the influence of immunosuppressive tumor microenvironment gets polarized to tumor-promoting and immunosuppressive macrophages, known as tumor-associated macrophages (TAM). Their recruitment and increased density in the plethora of tumors has been associated with poor prognosis in cancer patients. Therefore, retuning of TAM to M1 phenotype would be a key for effective immunotherapy. Radiotherapy has been a potential non-invasive strategy to improve cancer immunotherapy and tumor immune rejection. Irradiation of late-stage tumor-bearing Rip1-Tag5 mice twice with 2 Gy dose resulted in profound changes in the inflammatory tumor micromilieu, characterized by induction of M1-associated effecter cytokines as well as reduction in protumorigenic and M2-associated effecter cytokines. Similarly, in vitro irradiation of macrophages with 2 Gy dose-induced expression of iNOS, NO, NFκBpp65, pSTAT3 and proinflammatory cytokines secretion while downregulating p38MAPK which are involved in iNOS translation and acquisition of an M1-like phenotype. Enhancement of various M2 effecter cytokines and angiogenic reprogramming in iNOs+ macrophage depleted tumors and their subsequent reduction by 2 Gy dose in Rip1-Tag5 transgenic mice furthermore demonstrated a critical role of peritumoral macrophages in the course of gamma irradiation mediated M1 retuning of insulinoma.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26785731     DOI: 10.1093/carcin/bgw007

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  28 in total

Review 1.  Mini-review of conventional and hypofractionated radiation therapy combined with immunotherapy for non-small cell lung cancer.

Authors:  Allison M Campbell; Roy H Decker
Journal:  Transl Lung Cancer Res       Date:  2017-04

Review 2.  Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.

Authors:  Akshay Malhotra; Uttam Sharma; Shyamly Puhan; Naga Chandra Bandari; Anjali Kharb; P P Arifa; Lovlesh Thakur; Hridayesh Prakash; Karen M Vasquez; Aklank Jain
Journal:  Biochimie       Date:  2018-10-13       Impact factor: 4.079

3.  NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy.

Authors:  Qiuji Wu; Awatef Allouch; Audrey Paoletti; Celine Leteur; Celine Mirjolet; Isabelle Martins; Laurent Voisin; Frédéric Law; Haithem Dakhli; Elodie Mintet; Maxime Thoreau; Zeinaf Muradova; Mélanie Gauthier; Olivier Caron; Fabien Milliat; David M Ojcius; Filippo Rosselli; Eric Solary; Nazanine Modjtahedi; Eric Deutsch; Jean-Luc Perfettini
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

Review 4.  The effects of radiation therapy on the macrophage response in cancer.

Authors:  Callum Beach; David MacLean; Dominika Majorova; James N Arnold; Monica M Olcina
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

5.  Low dose radiation primed iNOS + M1macrophages modulate angiogenic programming of tumor derived endothelium.

Authors:  Vinod Nadella; Sandhya Singh; Aklank Jain; Manju Jain; Karen M Vasquez; Ashok Sharma; Pranay Tanwar; Goura Kishore Rath; Hridayesh Prakash
Journal:  Mol Carcinog       Date:  2018-08-10       Impact factor: 4.784

6.  Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas.

Authors:  Derui Yan; Qi Zhao; Zixuan Du; Huijun Li; Ruirui Geng; Wei Yang; Xinyan Zhang; Jianping Cao; Nengjun Yi; Juying Zhou; Zaixiang Tang
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

7.  M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma.

Authors:  Marine M Leblond; Elodie A Pérès; Charly Helaine; Aurélie N Gérault; Damien Moulin; Clément Anfray; Didier Divoux; Edwige Petit; Myriam Bernaudin; Samuel Valable
Journal:  Oncotarget       Date:  2017-08-07

Review 8.  Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies.

Authors:  Géraldine Genard; Stéphane Lucas; Carine Michiels
Journal:  Front Immunol       Date:  2017-07-14       Impact factor: 7.561

9.  CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma.

Authors:  Hridayesh Prakash; Vinod Nadella; Sandhya Singh; Hubertus Schmitz-Winnenthal
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

Review 10.  Radiation effects on antitumor immune responses: current perspectives and challenges.

Authors:  Thomas Walle; Rafael Martinez Monge; Adelheid Cerwenka; Daniel Ajona; Ignacio Melero; Fernando Lecanda
Journal:  Ther Adv Med Oncol       Date:  2018-01-18       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.